🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s PCVX Holdings & Trades

First Buy
Q3 2022
Duration Held
17 Quarters
Largest Add
Q3 2026
+17,582 Shares
Current Position
52,145 Shares
$2.97 M Value

Cliff Asness's PCVX Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 52,145 shares of Vaxcyte, Inc. (PCVX) worth $2.97 M, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 17 quarters.

Based on 13F filings, Cliff Asness has maintained a strategic position in PCVX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2026, adding 17,582 shares. Largest reduction occurred in Q1 2025, reducing 17,944 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Vaxcyte (PCVX) Holding Value Over Time

Track share changes against reported price movement

Quarterly Vaxcyte (PCVX) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +17,582 Add 50.87% 52,145 $56.90
Q2 2026 +9,105 Add 35.76% 34,563 $58.13
Q1 2026 +10,696 Add 72.46% 25,458 $58.11
Q4 2025 +14,762 New Buy 14,762 $46.14
Q3 2025 -6,381 Sold Out 0 $0.00
Q2 2025 -191 Reduce 2.91% 6,381 $32.51
Q1 2025 -17,944 Reduce 73.19% 6,572 $37.76
Q4 2024 +13,403 Add 120.61% 24,516 $81.86
Q3 2024 +253 Add 2.33% 11,113 $114.27
Q2 2024 +328 Add 3.11% 10,860 $75.51
Q1 2024 -1,568 Reduce 12.96% 10,532 $68.31
Q4 2023 -400 Reduce 3.20% 12,100 $62.80
Q3 2023 -1,870 Reduce 13.01% 12,500 $50.98
Q2 2023 +1,627 Add 12.77% 14,370 $49.94
Q1 2023 +1,306 Add 11.42% 12,743 $37.48
Q4 2022 +2,111 Add 22.64% 11,437 $47.95
Q3 2022 +9,326 New Buy 9,326 $24.02

Cliff Asness's Vaxcyte Investment FAQs

Cliff Asness first purchased Vaxcyte, Inc. (PCVX) in Q3 2022, acquiring 9,326 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Vaxcyte, Inc. (PCVX) for 17 quarters since Q3 2022.

Cliff Asness's largest addition to Vaxcyte, Inc. (PCVX) was in Q3 2026, adding 52,145 shares worth $2.97 M.

According to the latest 13F filing for Q3 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 52,145 shares of Vaxcyte, Inc. (PCVX), valued at approximately $2.97 M.

As of the Q3 2026 filing, Vaxcyte, Inc. (PCVX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in Vaxcyte, Inc. (PCVX) was 52,145 shares, as reported at the end of Q3 2026.